{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:09:44Z","timestamp":1789790984311,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11030-025-11183-w","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:12:02Z","timestamp":1744189922000},"page":"509-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Synthesis of porphyrin-formononetin derivatives and their anti-tumor activity studies"],"prefix":"10.1007","volume":"30","author":[{"given":"Lingyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejie","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufeng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiding","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"11183_CR1","doi-asserted-by":"publisher","first-page":"115441","DOI":"10.1016\/j.bcp.2023.115441","volume":"209","author":"H Zhou","year":"2023","unstructured":"Zhou H, Tan L, Liu B, Guan XY (2023) Cancer stem cells: recent insights and therapies. Biochem Pharmacol 209:115441. https:\/\/doi.org\/10.1016\/j.bcp.2023.115441","journal-title":"Biochem Pharmacol"},{"key":"11183_CR2","doi-asserted-by":"publisher","first-page":"111302","DOI":"10.1016\/j.biopha.2021.111302","volume":"137","author":"E Osta\u0144ska","year":"2021","unstructured":"Osta\u0144ska E, Aebisher D, Bartusik-Aebisher D (2021) The potential of photodynamic therapy in current breast cancer treatment methodologies. Biomed Pharmacother 137:111302. https:\/\/doi.org\/10.1016\/j.biopha.2021.111302","journal-title":"Biomed Pharmacother"},{"key":"11183_CR3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.biopha.2018.07.049","volume":"106","author":"S Kwiatkowski","year":"2018","unstructured":"Kwiatkowski S, Knap B, Przystupski D et al (2018) Photodynamic therapy mechanisms, photosensitizers and combinations. Biomed Pharmacother 106:1098\u20131107. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.049","journal-title":"Biomed Pharmacother"},{"key":"11183_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7150\/thno.67300","volume":"12","author":"B Ji","year":"2022","unstructured":"Ji B, Wei MJ, Yang B (2022) Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy. Theranostics 12:434\u2013458. https:\/\/doi.org\/10.7150\/thno.67300","journal-title":"Theranostics"},{"key":"11183_CR5","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1089\/ars.2018.7555","volume":"30","author":"M Yang","year":"2019","unstructured":"Yang M, Tao J, Wu H et al (2019) Aanat knockdown and melatonin supplementation in embryo development: involvement of mitochondrial function and DNA methylation. Antioxid Redox Signal 30:2050\u20132065. https:\/\/doi.org\/10.1089\/ars.2018.7555","journal-title":"Antioxid Redox Signal"},{"key":"11183_CR6","doi-asserted-by":"publisher","first-page":"e2102470","DOI":"10.1002\/smll.202102470","volume":"17","author":"XY Li","year":"2021","unstructured":"Li XY, Deng FA, Zheng RR et al (2021) Carrier free photodynamic synergists for oxidative damage amplified tumor therapy. Small 17:e2102470. https:\/\/doi.org\/10.1002\/smll.202102470","journal-title":"Small"},{"key":"11183_CR7","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1038\/s41467-022-33924-3","volume":"13","author":"KX Teng","year":"2022","unstructured":"Teng KX, Niu LY, Xie N, Yang QZ (2022) Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical. Nat Commun 13:6179. https:\/\/doi.org\/10.1038\/s41467-022-33924-3","journal-title":"Nat Commun"},{"key":"11183_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1871520620666200318101037","volume":"21","author":"MR Hamblin","year":"2021","unstructured":"Hamblin MR, Abrahamse H (2021) Factors affecting photodynamic therapy and anti-tumor immune response. Anticancer Agents Med Chem 21:123\u2013136. https:\/\/doi.org\/10.2174\/1871520620666200318101037","journal-title":"Anticancer Agents Med Chem"},{"key":"11183_CR9","doi-asserted-by":"publisher","first-page":"4793","DOI":"10.7150\/ijbs.87492","volume":"19","author":"BY Deng","year":"2023","unstructured":"Deng BY, Wang KP, Zhang LL et al (2023) Photodynamic therapy for inflammatory and cancerous diseases of the intestines: molecular mechanisms and prospects for application. Int J Biol Scii 19:4793\u20134810. https:\/\/doi.org\/10.7150\/ijbs.87492","journal-title":"Int J Biol Scii"},{"key":"11183_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12951-022-01691-4","volume":"20","author":"P He","year":"2022","unstructured":"He P, Yang GH, Zhu DZ et al (2022) Biomolecule-mimetic nanomaterials for photothermal and photodynamic therapy of cancers: bridging nanobiotechnology and biomedicine. J Nanobiotechnology 20:483. https:\/\/doi.org\/10.1186\/s12951-022-01691-4","journal-title":"J Nanobiotechnology"},{"key":"11183_CR11","doi-asserted-by":"publisher","first-page":"115926","DOI":"10.1016\/j.bmc.2020.115926","volume":"30","author":"K Janas","year":"2021","unstructured":"Janas K, Boniewska-Bernacka E, Dyrda G et al (2021) Porphyrin and phthalocyanine photosensitizers designed for targeted photodynamic therapy of colorectal cancer. Bioorg Med Chem 30:115926. https:\/\/doi.org\/10.1016\/j.bmc.2020.115926","journal-title":"Bioorg Med Chem"},{"key":"11183_CR12","doi-asserted-by":"publisher","first-page":"892","DOI":"10.3390\/molecules23040892","volume":"23","author":"U Chitgupi","year":"2018","unstructured":"Chitgupi U, Lovell J, Rajendiran V (2018) Assessing photosensitizer targeting using meso-tetra(carboxyphenyl) porphyrin. Molecules 23:892. https:\/\/doi.org\/10.3390\/molecules23040892","journal-title":"Molecules"},{"key":"11183_CR13","doi-asserted-by":"publisher","first-page":"6792","DOI":"10.1021\/acs.jmedchem.1c00052","volume":"64","author":"NA Le","year":"2021","unstructured":"Le NA, Babu V, Kalt M et al (2021) Photostable platinated bacteriochlorins as potent photodynamic agents. J Med Chem 64:6792\u20136801. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00052","journal-title":"J Med Chem"},{"key":"11183_CR14","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3390\/pharmaceutics15041284","volume":"15","author":"YS Bortnevskaya","year":"2023","unstructured":"Bortnevskaya YS, Shiryaev NA, Zakharov NS et al (2023) Synthesis and biological properties of EGFR-targeted photosensitizer based on cationic porphyrin. Pharmaceutics 15:1248. https:\/\/doi.org\/10.3390\/pharmaceutics15041284","journal-title":"Pharmaceutics"},{"key":"11183_CR15","doi-asserted-by":"publisher","first-page":"908378","DOI":"10.3389\/fnint.2022.908378","volume":"16","author":"X Ma","year":"2022","unstructured":"Ma X, Wang J (2022) Formononetin: a pathway to protect neurons. Front Integr Neurosci 16:908378. https:\/\/doi.org\/10.3389\/fnint.2022.908378","journal-title":"Front Integr Neurosci"},{"key":"11183_CR16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.3892\/or.2019.7432","volume":"43","author":"JS Oh","year":"2020","unstructured":"Oh JS, Kim TH, Park JH et al (2020) Formononetin induces apoptotic cell death through the suppression of mitogen-activated protein kinase and nuclear factor-kappaB phosphorylation in FaDu human head and neck squamous cell carcinoma cells. Oncol Rep 43:700\u2013710. https:\/\/doi.org\/10.3892\/or.2019.7432","journal-title":"Oncol Rep"},{"key":"11183_CR17","doi-asserted-by":"publisher","first-page":"108899","DOI":"10.1016\/j.jnutbio.2021.108899","volume":"100","author":"JY Wang","year":"2022","unstructured":"Wang JY, Jiang MW, Li MY et al (2022) Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation. J Nutr Biochem 100:108899. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108899","journal-title":"J Nutr Biochem"},{"key":"11183_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.24976\/Discov.Med.202436182.58","volume":"36","author":"HM Liu","year":"2018","unstructured":"Liu HM, Wang ZP, Liu ZG (2018) Formononetin restrains tumorigenesis of breast tumor by restraining STING-NF-\u03baB and interfering with the activation of PD-L1. Discov Med 36:613\u2013620. https:\/\/doi.org\/10.24976\/Discov.Med.202436182.58","journal-title":"Discov Med"},{"key":"11183_CR19","doi-asserted-by":"publisher","first-page":"566","DOI":"10.2174\/1871527318666190807160137","volume":"18","author":"X Fu","year":"2019","unstructured":"Fu X, Qin T, Yu J et al (2019) Formononetin ameliorates cognitive disorder via pgc-1alpha pathway in neuroinflammation conditions in high-fat diet-induced mice. CNS Neurol Disord Drug Targets 18:566\u2013577. https:\/\/doi.org\/10.2174\/1871527318666190807160137","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"11183_CR20","doi-asserted-by":"publisher","first-page":"112836","DOI":"10.1016\/j.biopha.2022.112836","volume":"149","author":"L Yu","year":"2022","unstructured":"Yu L, Zhang Y, Chen Q et al (2022) Formononetin protects against inflammation associated with cerebral ischemia-reperfusion injury in rats by targeting the JAK2\/STAT3 signaling pathway. Biomed Pharmacother 149:112836. https:\/\/doi.org\/10.1016\/j.biopha.2022.112836","journal-title":"Biomed Pharmacother"},{"key":"11183_CR21","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.7150\/thno.38115","volume":"10","author":"C Ma","year":"2020","unstructured":"Ma C, Xia R, Yang S et al (2020) Formononetin attenuates atherosclerosis via regulating interaction between KLF4 and SRA in apoE(-\/-) mice. Theranostics 10:1090\u20131106. https:\/\/doi.org\/10.7150\/thno.38115","journal-title":"Theranostics"},{"key":"11183_CR22","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuro.2021.05.014","volume":"85","author":"M Sugimoto","year":"2021","unstructured":"Sugimoto M, Ko R, Goshima H et al (2021) Formononetin attenuates H2O2-induced cell death through decreasing ROS level by PI3K\/Akt-Nrf2-activated antioxidant gene expression and suppressing MAPK-regulated apoptosis in neuronal SH-SY5Y cells. Neurotoxicology 85:186\u2013200. https:\/\/doi.org\/10.1016\/j.neuro.2021.05.014","journal-title":"Neurotoxicology"},{"key":"11183_CR23","doi-asserted-by":"publisher","first-page":"115811","DOI":"10.1016\/j.biopha.2023.115811","volume":"168","author":"S Aliya","year":"2023","unstructured":"Aliya S, Alhammadi M, Park U et al (2023) The potential role of formononetin in cancer treatment: an updated review. J Biomed Pharmacother 168:115811. https:\/\/doi.org\/10.1016\/j.biopha.2023.115811","journal-title":"J Biomed Pharmacother"},{"key":"11183_CR24","doi-asserted-by":"publisher","first-page":"129975","DOI":"10.1016\/j.foodchem.2021.129975","volume":"359","author":"J Machado Dutra","year":"2021","unstructured":"Machado Dutra J, Espitia PJP, Andrade Batista R (2021) Formononetin: biological effects and uses - a review. Food Chem 359:129975. https:\/\/doi.org\/10.1016\/j.foodchem.2021.129975","journal-title":"Food Chem"},{"key":"11183_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.4149\/gpb_2017004","volume":"36","author":"D Sun","year":"2017","unstructured":"Sun D, Lu Y, Zhang SJ et al (2017) Research on the effect of formononetin on photodynamic therapy in K562 cells. Gen Physiol Biophys 36:423\u2013430. https:\/\/doi.org\/10.4149\/gpb_2017004","journal-title":"Gen Physiol Biophys"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11183-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11183-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11183-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T15:56:40Z","timestamp":1771775800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11183-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11183"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11183-w","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}